Scherr D - Search Results

1

Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.

Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP. Kleinmann N, et al. Among authors: scherr d. Lancet Oncol. 2020 Jun;21(6):776-785. doi: 10.1016/S1470-2045(20)30147-9. Epub 2020 Apr 29. Lancet Oncol. 2020. PMID: 32631491 Clinical Trial.

2

Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.

Shelton JB, Barocas DA, Conway F, Hart K, Nelson K, Richstone L, Gonzalez RR, Raman JD, Scherr DS. Shelton JB, et al. Among authors: scherr ds. Urology. 2005 May;65(5):931-6. doi: 10.1016/j.urology.2004.11.047. Urology. 2005. PMID: 15882726

3

Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.

Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS. Raman JD, et al. Among authors: scherr ds. BJU Int. 2005 Nov;96(7):1031-5. doi: 10.1111/j.1464-410X.2005.05804.x. BJU Int. 2005. PMID: 16225523

4

Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.

Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: scherr ds. Carcinogenesis. 2006 Mar;27(3):499-507. doi: 10.1093/carcin/bgi299. Epub 2005 Dec 12. Carcinogenesis. 2006. PMID: 16344273

5

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.

Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: scherr ds. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8570-6. doi: 10.1158/1078-0432.CCR-05-1047. Clin Cancer Res. 2005. PMID: 16361539

6

Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.

Raman JD, Sosa RE, Vaughan ED Jr, Scherr DS. Raman JD, et al. Among authors: scherr ds. Urology. 2007 Feb;69(2):251-4. doi: 10.1016/j.urology.2006.09.065. Urology. 2007. PMID: 17320658

7

Hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.

Raman JD, Palese MA, Ng CK, Boorjian SA, Scherr DS, Del Pizzo JJ, Sosa RE. Raman JD, et al. Among authors: scherr ds. JSLS. 2006 Oct-Dec;10(4):432-8. JSLS. 2006. PMID: 17575752 Free PMC article.

8

Robotic radical prostatectomy: operative technique, outcomes, and learning curve.

Raman JD, Dong S, Levinson A, Samadi D, Scherr DS. Raman JD, et al. Among authors: scherr ds. JSLS. 2007 Jan-Mar;11(1):1-7. JSLS. 2007. PMID: 17651548 Free PMC article.

9

Management of patients with upper urinary tract transitional cell carcinoma.

Raman JD, Scherr DS. Raman JD, et al. Among authors: scherr ds. Nat Clin Pract Urol. 2007 Aug;4(8):432-43. doi: 10.1038/ncpuro0875. Nat Clin Pract Urol. 2007. PMID: 17673914 Review.

10

Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.

Wang GJ, Barocas DA, Raman JD, Scherr DS. Wang GJ, et al. Among authors: scherr ds. BJU Int. 2008 Jan;101(1):89-93. doi: 10.1111/j.1464-410X.2007.07212.x. Epub 2007 Sep 20. BJU Int. 2008. PMID: 17888044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters